Search for: "Wyeth Pharmaceuticals, Inc. "
Results 101 - 120
of 517
Sorted by Relevance
|
Sort by Date
29 Jun 2009, 10:37 am
Due to the March 2009 Supreme Court ruling in Wyeth v. [read post]
13 Nov 2008, 1:52 pm
Wyeth, which is now available at 2008 WL 4823066 (Cal. [read post]
30 Dec 2009, 6:27 pm
Wyeth Inc., 25 No. 11 Andrews Pharmaceutical Litig. [read post]
11 Feb 2010, 11:22 am
Wyeth, Inc., 85 Cal. [read post]
23 Feb 2010, 4:30 am
Wyeth, Inc., 168 Cal. [read post]
31 Mar 2016, 3:00 am
Ortho-McNeil Pharm., Inc., 808 F.3d 281 (6th Cir 2015). [read post]
28 Nov 2009, 7:11 am
Wyeth, Inc., No. 08-3850, slip op. (8th Cir. [read post]
20 Mar 2009, 2:05 am
Wyeth Laboratories, Inc., 669 F.Supp. 212, 215 (N.D. [read post]
13 Jan 2018, 8:00 pm
Wyeth, Inc. [read post]
29 Oct 2008, 12:00 pm
The Wyeth v. [read post]
23 Jan 2009, 11:58 pm
Inc. analyst Timothy Anderson predicted that Pfizer would cut 70 percent of Wyeth's current $10 billion budget for research and development, and for marketing and administrative expenses.He based his estimates on an eventual sale price of $65 billion.At the Wyeth Pharmaceuticals campus in Malvern yesterday, workers, most of whom declined to give their names, said they had heard almost nothing. [read post]
26 Jun 2013, 6:30 am
Patent Litigation Settlement RoundupOn November 8, 2012, Mylan Inc. [read post]
27 Aug 2017, 10:01 pm
Actavis, Inc. [read post]
27 Aug 2017, 10:01 pm
Actavis, Inc. [read post]
9 May 2013, 5:34 am
Our Montgomery personal injury lawyers understand the 8-1 ruling in this case, Wyeth Inc. v. [read post]
15 Jun 2012, 11:20 am
Wyeth Laboratories Inc., 161 N.J. 1, 14-15 (1999). [read post]
21 May 2012, 9:16 am
Supreme Court (PLIVA, INC., ET AL. v. [read post]
22 Feb 2011, 5:02 pm
Pfizer, Inc. also agreed to settle more than 2,200 lawsuits alleging that the company hid Prempo’s cancer risks. [read post]
9 Sep 2011, 8:40 am
Rost was a Vice President, Marketing and Managing Director for Wyeth, responsible for the Nordic region in Europe.Dr. [read post]
3 Aug 2009, 7:29 am
All responding defendants (Actavis, Inc.; Actavis-Elizabeth, L.L.C.; Barr Pharmaceuticals, Inc.; Baxter Healthcare Corp.; Duramed Pharmaceuticals, Inc.; Pliva, Inc.; Pliva USA, Inc.; Schwarz Pharma, Inc.; Teva Pharmaceuticals USA, Inc.; and Wyeth) opposed centralization, as did one Plaintiff from Vermont. [read post]
